Stocks
Health Care
rgnx
Regenxbio
NASDAQ: RGNX
-0.10 (-1.16%)
8.53
USD
At close at Apr 03, 17:40 UTC
Income Statement
Revenue
83.33M
Gross Profit
49.76M
Operating Income
-233.35M
Pretax Income
-177.92M
Net Income
-227.10M
EBITDA
-198.23M
EBIT
-214.44M
Earnings Per Share
-4.6
Balance Sheet
Cash & Cash Equivalents
73.25M
Total Debt
154.20M
Net Cash
-
Net Cash Per Share
-
Equity (Book Value)
325.00M
Book Value Per Share
6.75
Working Capital
-
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.